Danish pharmaceutical company Novo Nordisk is set to launch its anti-diabetes and weight-loss drug Wegovy in India, aiming to ...

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults ...

The 76-year-old Oscar winner got serious about her health following her diagnosis for type 2 diabetes in 2017, but there was a moment six years prior that truly sparked her weight-loss journey ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

For example, Rybelsus costs about $997 a month before insurance, the same list price as Ozempic. Risinger said he expects orforglipron to be priced at a slight discount to Zepbound, which means ...